Association of Serum ELMO-3 Levels with Metastatic Status and Survival Outcomes in Non-Small Cell Lung Cancer.

Curr Issues Mol Biol · 2026 · PMC13115388 · PMID 42042087

Europe PMC DOI

hedged sentences

0.0600

closest p · 1.2× alpha

0.1280

boldest claim

The sentences

a trend toward significancep = 0.060so close (0.05 < p ≤ 0.1)

Furthermore, overall stage demonstrated a trend toward significance, with patients in early stage showing longer PFS compared with late stage (45.0 vs. 22.0 months, p = 0.060).

also in 2,361 other papers

showed a trendp = 0.088so close (0.05 < p ≤ 0.1)

Similarly, radiotherapy showed a trend toward association with PFS, with patients receiving radiotherapy demonstrating longer survival estimates (38.8 vs. 21.5 months, p = 0.088).

also in 31,039 other papers

did not reach statistical significancep = 0.128not close (p > 0.1)

Although the differences did not reach statistical significance ( p = 0.128), patients who received radiotherapy and had low ELMO-3 expression demonstrated the longest survival, with a median OS of 48.9 months (95% CI: 31.65–66.21).

also in 61,332 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.